Glucose Health (OTCMKTS:GLUC – Get Free Report) and Sanuwave Health (NASDAQ:SNWV – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, dividends, analyst recommendations and risk.
Risk & Volatility
Glucose Health has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, Sanuwave Health has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500.
Institutional and Insider Ownership
42.5% of Sanuwave Health shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Glucose Health | $340,000.00 | 25.97 | -$230,000.00 | ($0.03) | -11.00 |
| Sanuwave Health | $44.05 million | 3.12 | $11.81 million | ($0.16) | -100.00 |
Sanuwave Health has higher revenue and earnings than Glucose Health. Sanuwave Health is trading at a lower price-to-earnings ratio than Glucose Health, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Glucose Health and Sanuwave Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Glucose Health | -59.22% | N/A | N/A |
| Sanuwave Health | 26.64% | -141.56% | 34.53% |
Analyst Recommendations
This is a breakdown of recent ratings for Glucose Health and Sanuwave Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Glucose Health | 0 | 0 | 0 | 0 | 0.00 |
| Sanuwave Health | 1 | 1 | 1 | 1 | 2.50 |
Sanuwave Health has a consensus target price of $51.00, indicating a potential upside of 218.75%. Given Sanuwave Health’s stronger consensus rating and higher probable upside, analysts plainly believe Sanuwave Health is more favorable than Glucose Health.
Summary
Sanuwave Health beats Glucose Health on 11 of the 15 factors compared between the two stocks.
About Glucose Health
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.
About Sanuwave Health
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company’s lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body’s normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.
Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.
